Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Magliocca

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter StudyBin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2022
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastomaMatt Lechner, Yoko Takahashi, Mario Turri-Zanoni, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2023
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter StudyBin Xu, Kartik Viswanathan, Mahsa S Ahadi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2022
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastomaMatt Lechner, Yoko Takahashi, Mario Turri-Zanoni, et al.
Pageof 4